Artykuły w czasopismach na temat „Picropodophylline”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Picropodophylline”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Roulland, Emmanuel, Emmanuel Bertounesque, Christiane Huel i Claude Monneret. "Synthesis of picropodophyllin homolactone". Tetrahedron Letters 41, nr 35 (sierpień 2000): 6769–73. http://dx.doi.org/10.1016/s0040-4039(00)01136-9.
Pełny tekst źródłaRoulland, Emmanuel, Emmanuel Bertounesque, Christiane Huel i Claude Monneret. "ChemInform Abstract: Synthesis of Picropodophyllin Homolactone." ChemInform 31, nr 45 (7.11.2000): no. http://dx.doi.org/10.1002/chin.200045231.
Pełny tekst źródłaWen, Pu Hong. "Kinetic Investigation of Thermal Decomposition Reactions of Podophyllic Acid and Picropodophyllic Acid". Advanced Materials Research 391-392 (grudzień 2011): 1230–34. http://dx.doi.org/10.4028/www.scientific.net/amr.391-392.1230.
Pełny tekst źródłaGuo, Hong Zhu, De An Guo, Xue Yan Fei, Ya Jun Cui i Jun Hua Zheng. "Biotransformation of Podophyllotoxin to Picropodophyllin by Microbes". Journal of Asian Natural Products Research 1, nr 2 (grudzień 1998): 99–102. http://dx.doi.org/10.1080/10286029808039850.
Pełny tekst źródłaOhshima-Hosoyama, Sachiko, Tohru Hosoyama, Laura D. Nelon i Charles Keller. "IGF-1 receptor inhibition by picropodophyllin in medulloblastoma". Biochemical and Biophysical Research Communications 399, nr 4 (wrzesień 2010): 727–32. http://dx.doi.org/10.1016/j.bbrc.2010.08.009.
Pełny tekst źródłaWu, Qi, Ai-Ling Tian, Guido Kroemer i Oliver Kepp. "Autophagy induction by IGF1R inhibition with picropodophyllin and linsitinib". Autophagy 17, nr 8 (10.06.2021): 2046–47. http://dx.doi.org/10.1080/15548627.2021.1936934.
Pełny tekst źródłaBerkowitz, David B., Sungjo Choi i Jun-Ho Maeng. "Enzyme-Assisted Asymmetric Total Synthesis of (−)-Podophyllotoxin and (−)-Picropodophyllin". Journal of Organic Chemistry 65, nr 3 (luty 2000): 847–60. http://dx.doi.org/10.1021/jo991582+.
Pełny tekst źródłaPohmakotr, Manat, Taweechote Komutkul, Patoomratana Tuchinda, Samrarn Prabpai, Palangpon Kongsaeree i Vichai Reutrakul. "Syntheses of (±)-thuriferic acid ethyl ester, its analogues and (±)-picropodophyllone". Tetrahedron 61, nr 22 (maj 2005): 5311–21. http://dx.doi.org/10.1016/j.tet.2005.03.069.
Pełny tekst źródłaPullin, Robert D. C., Jonathan D. Sellars i Patrick G. Steel. "Silenes in organic synthesis: a concise synthesis of (±)-epi-picropodophyllin". Organic & Biomolecular Chemistry 5, nr 19 (2007): 3201. http://dx.doi.org/10.1039/b710370k.
Pełny tekst źródłaColón, Eugenia, Farasat Zaman, Magnus Axelson, Olle Larsson, Christine Carlsson-Skwirut, Konstantin V. Svechnikov i Olle Söder. "Insulin-Like Growth Factor-I Is an Important Antiapoptotic Factor for Rat Leydig Cells during Postnatal Development". Endocrinology 148, nr 1 (1.01.2007): 128–39. http://dx.doi.org/10.1210/en.2006-0835.
Pełny tekst źródłaZhao, Jing, Yajing Wang i Libiao Luan. "Star-Shaped Polycaprolactone-Polyethyleneglycol Copolymer Micelle-Like Nanoparticles for Picropodophyllin Delivery". Journal of Biomedical Nanotechnology 10, nr 8 (1.08.2014): 1627–34. http://dx.doi.org/10.1166/jbn.2014.1835.
Pełny tekst źródłaHashemi, Jamileh, Claire Worrall, Daiana Vasilcanu, Mårten Fryknäs, Luqman Sulaiman, Mohsen Karimi, Wen-Hui Weng i in. "Molecular Characterization of Acquired Tolerance of Tumor Cells to Picropodophyllin (PPP)". PLoS ONE 6, nr 3 (14.03.2011): e14757. http://dx.doi.org/10.1371/journal.pone.0014757.
Pełny tekst źródłaLu, Xiaosheng, Ledan Wang, Jie Mei, Xin Wang, Xueqiong Zhu, Qiong Zhang i Jieqiang Lv. "Picropodophyllin inhibits epithelial ovarian cancer cells in vitro and in vivo". Biochemical and Biophysical Research Communications 435, nr 3 (czerwiec 2013): 385–90. http://dx.doi.org/10.1016/j.bbrc.2013.04.097.
Pełny tekst źródłaBerkowitz, David B., Sungjo Choi i Jun-Ho Maeng. "ChemInform Abstract: Enzyme-Assisted Asymmetric Total Synthesis of (-)-Podophyllotoxin and (-)-Picropodophyllin." ChemInform 31, nr 23 (8.06.2010): no. http://dx.doi.org/10.1002/chin.200023243.
Pełny tekst źródłaFENG, XIAOYING, EIMAN ALEEM, YINGBO LIN, MAGNUS AXELSON, OLLE LARSSON i THOMAS STRÖMBERG. "Multiple antitumor effects of picropodophyllin in colon carcinoma cell lines: Clinical implications". International Journal of Oncology 40, nr 4 (6.12.2011): 1251–58. http://dx.doi.org/10.3892/ijo.2011.1281.
Pełny tekst źródłaWu, Xuping, Linda Sooman, Malin Wickström, Mårten Fryknäs, Christine Dyrager, Johan Lennartsson i Joachim Gullbo. "Alternative Cytotoxic Effects of the Postulated IGF-IR Inhibitor Picropodophyllin In Vitro". Molecular Cancer Therapeutics 12, nr 8 (22.05.2013): 1526–36. http://dx.doi.org/10.1158/1535-7163.mct-13-0091.
Pełny tekst źródłaYin, Shu-Cheng, Wei Guo i Ze-Zhang Tao. "Picropodophyllin inhibits tumor growth of human nasopharyngeal carcinoma in a mouse model". Biochemical and Biophysical Research Communications 439, nr 1 (wrzesień 2013): 1–5. http://dx.doi.org/10.1016/j.bbrc.2013.08.050.
Pełny tekst źródłaVitale, Maxime, Guillaume Prestat, David Lopes, David Madec, Claire Kammerer, Giovanni Poli i Leonard Girnita. "New Picropodophyllin Analogs via Palladium-Catalyzed Allylic Alkylation−Hiyama Cross-Coupling Sequences". Journal of Organic Chemistry 73, nr 15 (sierpień 2008): 5795–805. http://dx.doi.org/10.1021/jo800707q.
Pełny tekst źródłaOgiku, Tsuyoshi, Shin-ichi Yoshida, Tooru Kuroda, Masami Takahashi, Hiroshi Ohmizu i Tameo Iwasaki. "Syntheses of Aryltetralin Lignans: Concise Syntheses of (±)-Isopodophyllotoxone, (±)-Picropodophyllone and Their Related Compounds". Bulletin of the Chemical Society of Japan 65, nr 12 (grudzień 1992): 3495–97. http://dx.doi.org/10.1246/bcsj.65.3495.
Pełny tekst źródłaTOMIZAWA, MINORU, FUMINOBU SHINOZAKI, YASUFUMI MOTOYOSHI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO i MAKOTO SUEISHI. "Picropodophyllin and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells". Oncology Letters 8, nr 5 (27.08.2014): 2023–26. http://dx.doi.org/10.3892/ol.2014.2484.
Pełny tekst źródłaOGIKU, T., S. YOSHIDA, T. KURODA, M. TAKAHASHI, H. OHMIZU i T. IWASAKI. "ChemInform Abstract: Syntheses of Aryltetralin Lignans: Concise Syntheses of (.+-.)- Isopodophyllotoxone, (.+-.)-Picropodophyllone and Related Compounds." ChemInform 24, nr 15 (20.08.2010): no. http://dx.doi.org/10.1002/chin.199315280.
Pełny tekst źródłaWong Te Fong, Anne-Christine, Thomas R. Eykyn, Harry G. Parkes, Aleksandra Bielen, Chris Jones, Ian R. Judson, John R. Griffiths, Martin O. Leach i Yuen-Li Chung. "Abstract B61: Picropodophyllin (PPP) increases glucose metabolism and lactate production in paediatric glioblastoma cells". Clinical Cancer Research 18, nr 10 Supplement (15.05.2012): B61. http://dx.doi.org/10.1158/1078-0432.mechres-b61.
Pełny tekst źródłaMeresse, Philippe, Claude Monneret i Emmanuel Bertounesque. "Synthesis of podophyllotoxin analogues: δ-lactone-containing picropodophyllin, podophyllotoxin and 4′-demethyl-epipodophyllotoxin derivatives". Tetrahedron 60, nr 11 (marzec 2004): 2657–71. http://dx.doi.org/10.1016/j.tet.2004.01.017.
Pełny tekst źródłaLemaire, Miguel, Charlotte Fristedt, Prasoon Agarwal, Eline Menu, Els Van Valckenborgh, Elke De Bruyne, Anders Österborg i in. "The HDAC Inhibitor LBH589 Enhances the Antimyeloma Effects of the IGF-1RTK Inhibitor Picropodophyllin". Clinical Cancer Research 18, nr 8 (5.03.2012): 2230–39. http://dx.doi.org/10.1158/1078-0432.ccr-11-1764.
Pełny tekst źródłaZhang, Qi, Jing Pan, Ronald A. Lubet, Yian Wang i Ming You. "Targeting the insulin-like growth factor-1 receptor by picropodophyllin for lung cancer chemoprevention". Molecular Carcinogenesis 54, S1 (27.08.2014): E129—E137. http://dx.doi.org/10.1002/mc.22206.
Pełny tekst źródłaBieghs, Liesbeth, Susanne Lub, Karel Fostier, Ken Maes, Els Van Valckenborgh, Eline Menu, Hans E. Johnsen i in. "The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic". Oncotarget 5, nr 22 (30.04.2014): 11193–208. http://dx.doi.org/10.18632/oncotarget.1933.
Pełny tekst źródłaDong, Lin, Meirong Du i Qianzhou Lv. "Picropodophyllin inhibits type I endometrial cancer cell proliferation via disruption of the PI3K/Akt pathway". Acta Biochimica et Biophysica Sinica 51, nr 7 (6.06.2019): 753–60. http://dx.doi.org/10.1093/abbs/gmz055.
Pełny tekst źródłaYoshida, Shin-ichi, Takeshi Yamanaka, Tutomu Miyake, Yasunori Moritani, Hiroshi Ohmizu i Tameo Iwasaki. "Asymmetric syntheses of lignans utilizing novel diastereoselective Michael addition of cyanohydrin: Syntheses of (+)-fargesin and (−)-picropodophyllone". Tetrahedron 53, nr 28 (lipiec 1997): 9585–98. http://dx.doi.org/10.1016/s0040-4020(97)00643-1.
Pełny tekst źródłaYin, S., A. Girnita, T. Stromberg, Z. Khan, S. Andersson, H. Zheng, C. Ericsson i in. "Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma". Neuro-Oncology 12, nr 1 (20.10.2009): 19–27. http://dx.doi.org/10.1093/neuonc/nop008.
Pełny tekst źródłaYOSHIDA, S., T. YAMANAKA, T. MIYAKE, Y. MORITANI, H. OHMIZU i T. IWASAKI. "ChemInform Abstract: Asymmetric Syntheses of Lignans Utilizing Novel Diastereoselective Michael Addition of Cyanohydrin: Syntheses of (+)-Fargesin and (-)- Picropodophyllone." ChemInform 28, nr 50 (2.08.2010): no. http://dx.doi.org/10.1002/chin.199750276.
Pełny tekst źródłaWaraky, Ahmed, Karen Akopyan, Vendela Parrow, Thomas Strömberg, Magnus Axelson, Lars Abrahmsén, Arne Lindqvist, Olle Larsson i Eiman Aleem. "Picropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via Insulin-like growth factor-1 receptor-independent mechanism". Oncotarget 5, nr 18 (31.07.2014): 8379–92. http://dx.doi.org/10.18632/oncotarget.2292.
Pełny tekst źródłaEconomou, Mario A., Sandra Andersson, Diana Vasilcanu, Charlotta All-Ericsson, Eline Menu, Ada Girnita, Leonard Girnita, Magnus Axelson, Stefan Seregard i Olle Larsson. "Oral Picropodophyllin (PPP) Is Well Tolerated In Vivo and Inhibits IGF-1R Expression and Growth of Uveal Melanoma". Investigative Opthalmology & Visual Science 49, nr 6 (1.06.2008): 2337. http://dx.doi.org/10.1167/iovs.07-0819.
Pełny tekst źródłaEconomou, Mario A., Sandra Andersson, Diana Vasilcanu, Charlotta All-Ericsson, Eline Menu, Ada Girnita, Leonard Girnita, Magnus Axelson, Stefan Seregard i Olle Larsson. "Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma". Acta Ophthalmologica 86, esis4 (19.11.2008): 35–41. http://dx.doi.org/10.1111/j.1755-3768.2008.01184.x.
Pełny tekst źródłaJiang, Li-hua, Nian-yun Yang, Xiao-lin Yuan, Yi-jie Zou, Ze-qun Jiang, Feng-ming Zhao, Jian-ping Chen, Ming-yan Wang i Da-xiang Lu. "Microarray Analysis of mRNA and MicroRNA Expression Profile Reveals the Role ofβ-Sitosterol-D-glucoside in the Proliferation of Neural Stem Cell". Evidence-Based Complementary and Alternative Medicine 2013 (2013): 1–12. http://dx.doi.org/10.1155/2013/360302.
Pełny tekst źródłaConti, Laura, Gabriella Regis, Angela Longo, Paola Bernabei, Roberto Chiarle, Mirella Giovarelli i Francesco Novelli. "In the absence of IGF-1 signaling, IFN-γ suppresses human malignant T-cell growth". Blood 109, nr 6 (5.12.2006): 2496–504. http://dx.doi.org/10.1182/blood-2006-07-034231.
Pełny tekst źródłaGong, Wan, Naidan Zhang, Gang Cheng, Quanlong Zhang, Yuqiong He, Yi Shen, Qi Zhang, Bo Zhu, Qiaoyan Zhang i Luping Qin. "Rehmannia glutinosa Libosch Extracts Prevent Bone Loss and Architectural Deterioration and Enhance Osteoblastic Bone Formation by Regulating the IGF-1/PI3K/mTOR Pathway in Streptozotocin-Induced Diabetic Rats". International Journal of Molecular Sciences 20, nr 16 (15.08.2019): 3964. http://dx.doi.org/10.3390/ijms20163964.
Pełny tekst źródłaWU, YONG-TAO, BAO-JUN WANG, SHENG-WU MIAO i JIAN-JUN GAO. "Picropodophyllin inhibits the growth of Ewing's sarcoma cells through the insulin-like growth factor-1 receptor/Akt signaling pathway". Molecular Medicine Reports 12, nr 5 (28.08.2015): 7045–50. http://dx.doi.org/10.3892/mmr.2015.4266.
Pełny tekst źródłaLiao, Fenfang, Yongheng Chen, Qingqing Wu, Jiaqi Wen, Xiangjie Chen, Weizhang Wang, Dan Xu i Manyu Liu. "Selective elimination of CML stem/progenitor cells by picropodophyllin in vitro and in vivo is associated with p53 activation". Biochemical and Biophysical Research Communications 579 (listopad 2021): 1–7. http://dx.doi.org/10.1016/j.bbrc.2021.09.029.
Pełny tekst źródłaVasilcanu, R., D. Vasilcanu, L. Rosengren, N. Natalishvili, B. Sehat, S. Yin, A. Girnita, M. Axelson, L. Girnita i O. Larsson. "Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and β-arrestin1". Oncogene 27, nr 11 (10.09.2007): 1629–38. http://dx.doi.org/10.1038/sj.onc.1210797.
Pełny tekst źródłaMo, Hai-Ying, Qi-Yao Wei, Qiu-Hua Zhong, Xiao-Yun Zhao, Dan Guo, Jin Han, Wachiraporn Noracharttiyapot i in. "Cytochrome P450 27C1 Level Dictates Lung Cancer Tumorigenicity and Sensitivity towards Multiple Anticancer Agents and Its Potential Interplay with the IGF-1R/Akt/p53 Signaling Pathway". International Journal of Molecular Sciences 23, nr 14 (16.07.2022): 7853. http://dx.doi.org/10.3390/ijms23147853.
Pełny tekst źródłaMenu, Eline, Helena Jernberg-Wiklund, Thomas Stromberg, Hendrik De Raeve, Leonard Girnita, Olle Larsson, Magnus Axelson i in. "Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model". Blood 107, nr 2 (15.01.2006): 655–60. http://dx.doi.org/10.1182/blood-2005-01-0293.
Pełny tekst źródłaTakata, Sho, Hiromi Sakata-Haga, Hiroki Shimada, Tsuyoshi Tsukada, Daisuke Sakai, Hiroki Shoji, Mitsuhiro Tomosugi i in. "LIF–IGF Axis Contributes to the Proliferation of Neural Progenitor Cells in Developing Rat Cerebrum". International Journal of Molecular Sciences 23, nr 21 (30.10.2022): 13199. http://dx.doi.org/10.3390/ijms232113199.
Pełny tekst źródłaRazuvaev, Anton, Bimma Henderson, Leonard Girnita, Olle Larsson, Magnus Axelson, Ulf Hedin i Joy Roy. "The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling". Journal of Vascular Surgery 46, nr 1 (lipiec 2007): 108–15. http://dx.doi.org/10.1016/j.jvs.2007.02.066.
Pełny tekst źródłaWu, Qi, Ai-Ling Tian, Bei Li, Marion Leduc, Sabrina Forveille, Peter Hamley, Warren Galloway i in. "IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms−". Journal for ImmunoTherapy of Cancer 9, nr 6 (czerwiec 2021): e002722. http://dx.doi.org/10.1136/jitc-2021-002722.
Pełny tekst źródłaEconomou, Mario A., Jiangmei Wu, Daiana Vasilcanu, Linda Rosengren, Charlotta All-Ericsson, Ingeborg van der Ploeg, Eline Menu i in. "Inhibition of VEGF Secretion and Experimental Choroidal Neovascularization by Picropodophyllin (PPP), an Inhibitor of the Insulin-like Growth Factor-1 Receptor". Investigative Opthalmology & Visual Science 49, nr 6 (1.06.2008): 2620. http://dx.doi.org/10.1167/iovs.07-0742.
Pełny tekst źródłaEconomou, Mario A., Jiangmei Wu, Daiana Vasilcanu, Linda Rosengren, Charlotta All-Ericsson, Ingeborg Van Der Ploeg, Eline Menu i in. "Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor". Acta Ophthalmologica 86, esis4 (19.11.2008): 42–49. http://dx.doi.org/10.1111/j.1755-3768.2008.01185.x.
Pełny tekst źródłaE, Changyong, Jing Li, Dan Shao, Dan Zhang, Yue Pan, Li Chen i Xuewen Zhang. "The Insulin-Like Growth Factor-I Receptor Inhibitor Picropodophyllin-Induced Selective Apoptosis of Hepatocellular Carcinoma Cell Through a Caspase-Dependent Mitochondrial Pathway". Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 21, nr 2 (10.01.2014): 103–10. http://dx.doi.org/10.3727/096504013x13808175127324.
Pełny tekst źródłaGirnita, Ada, Charlotta All-Ericsson, Mario A. Economou, Kristina Astr√∂m, Magnus Axelson, Stefan Seregard, Olle Larsson i Leonard Girnita. "The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells." Clinical Cancer Research 12, nr 4 (15.02.2006): 1383–91. http://dx.doi.org/10.1158/1078-0432.ccr-05-1106.
Pełny tekst źródłaDuan, Zhenfeng, Edwin Choy, David Harmon, Cao Yang, Keinosuke Ryu, Joseph Schwab, Henry Mankin i Francis J. Hornicek. "Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines". Molecular Cancer Therapeutics 8, nr 8 (28.07.2009): 2122–30. http://dx.doi.org/10.1158/1535-7163.mct-09-0115.
Pełny tekst źródłaGullbo, Joachim, Michael Bergqvist, Malin Wickström, Peter Ericsson, Linda Sooman, Daniel Brattström, Stefan Bergström i Simon Ekman. "P3-016: In vitro activity of picropodophyllin in lung cancer cell lines and association to the insulin-like Growth Factor-1 receptor". Journal of Thoracic Oncology 2, nr 8 (sierpień 2007): S613—S614. http://dx.doi.org/10.1097/01.jto.0000283773.72586.f8.
Pełny tekst źródła